Healthcare provider profile · identity verified

Jason Charles Evers, D.O.

Family Practice · YORKTOWN, VA · NPI 1235506387

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	263	39
Levothyroxine Sodium	Levothyroxine Sodium	221	42
Quetiapine Fumarate	Quetiapine Fumarate	165	30
Gabapentin	Gabapentin	164	34
Tramadol Hcl	Tramadol Hcl	153	40
Mirtazapine	Mirtazapine	151	28
Furosemide	Furosemide	142	25
Potassium Chloride	Potassium Chloride	141	20
Lisinopril	Lisinopril	137	23
Losartan Potassium	Losartan Potassium	130	20
Metoprolol Tartrate	Metoprolol Tartrate	121	18
Pantoprazole Sodium	Pantoprazole Sodium	118	23
Trazodone Hcl	Trazodone Hcl	118	22
Lorazepam	Lorazepam	105	47
Memantine Hcl	Memantine Hcl	104	23
Amlodipine Besylate	Amlodipine Besylate	103	23
Tamsulosin Hcl	Tamsulosin Hcl	99	21
Escitalopram Oxalate	Escitalopram Oxalate	96	16
Simvastatin	Simvastatin	96	11
Clonazepam	Clonazepam	94	13
Clopidogrel	Clopidogrel Bisulfate	93	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	35
Metformin Hcl	Metformin Hcl	80	13
Donepezil Hcl	Donepezil Hcl	75	17
Omeprazole	Omeprazole	74	18
Duloxetine Hcl	Duloxetine Hcl	71	suppressed
Carvedilol	Carvedilol	70	11
Buspirone Hcl	Buspirone Hcl	69	13
Metoprolol Succinate	Metoprolol Succinate	69	16
Sertraline Hcl	Sertraline Hcl	69	21
Divalproex Sodium	Divalproex Sodium	67	12
Alprazolam	Alprazolam	63	16
Montelukast Sodium	Montelukast Sodium	63	12
Bumetanide	Bumetanide	58	13
Fluoxetine Hcl	Fluoxetine Hcl	58	suppressed
Haloperidol Lactate	Haloperidol Lactate	58	52
Rosuvastatin Calcium	Rosuvastatin Calcium	57	11
Morphine Sulfate	Morphine Sulfate	50	44
Allopurinol	Allopurinol	48	suppressed
Famotidine	Famotidine	46	suppressed
Eliquis	Apixaban	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Oxcarbazepine	Oxcarbazepine	44	suppressed
Ketoconazole	Ketoconazole	42	suppressed
Aripiprazole	Aripiprazole	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Temazepam	Temazepam	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	14
Risperidone	Risperidone	33	suppressed
Finasteride	Finasteride	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Latanoprost	Latanoprost	30	suppressed
Lorazepam Intensol	Lorazepam	30	29
Xarelto	Rivaroxaban	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Primidone	Primidone	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Glipizide	Glipizide	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	11
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Nystatin	Nystatin	23	14
Olanzapine	Olanzapine	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Aripiprazole Odt	Aripiprazole	22	suppressed
Benztropine Mesylate	Benztropine Mesylate	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Torsemide	Torsemide	20	suppressed
Digoxin	Digoxin	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	17
Ezetimibe	Ezetimibe	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Diazepam	Diazepam	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Atenolol	Atenolol	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Clonidine	Clonidine	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hyoscyamine Sulfate	Hyoscyamine Sulfate	12	11
Myrbetriq	Mirabegron	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	11	suppressed
Nystop	Nystatin	11	suppressed
Permethrin	Permethrin	11	11
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error